[1] 曾妮,叶兴,黄河浪. 乙肝免疫球蛋白联合乙肝疫苗阻断乙型肝炎母婴传播的系统评价[J].中华疾病控制杂志,2017,21(01):48-51.
[2] 刘亚琳,卢颖,李杰. 乙型肝炎疫苗阻断母婴传播的新挑战:隐匿性感染[J].中华肝脏病杂志,2016,24(2):157-160.
[3] 苗静,袁晨翼,李秋伟,等. 慢性乙型肝炎病毒感染患者外周血CD4+、CD8+T细胞的表达与HBsAg定量的相关性分析[J].中国中西医结合急救杂志,2016,23(4):399-403.
[4] 聂颖坤,曾庆生. 新会区乙肝疫苗与乙肝免疫球蛋白联合阻断母婴传播免疫效果研究[J].中国现代药物应用,2016,10(01):162-164.
[5] 孙校金,王富珍,郑徽,等. 2014年中国六省份孕产妇乙型肝炎病毒表面抗原筛查及新生儿免疫预防调查分析[J].中国疫苗和免疫,2016,26(03):241-245.
[6] 王亚萍,刘惠媛,石裕明,等. 乙型肝炎病毒感染孕妇561例的临床特征及母婴阻断情况[J].广东医学,2018,39(04):569-572.
[7] 郑积才,陈和敏. 乙肝疫苗联合乙肝免疫球蛋白阻断乙肝母婴垂直传播的疗效及影响因素研究[J].中国全科医学,2017,20(S1):96-98.
[8] Zhand S, Tabarraei A, Nazari A,et al. Cytotoxic T lymphocytes and CD4 epitope mutations in the pre-core/core region of hepatitis B virus in chronic hepatitis B carriers in Northeast Iran[J].Indian J Gastroenterol,2017,36(4):253-257.
[9] Qi F, Zuo Z, Hu S, et al. An enriched environment restores hepatitis B vaccination-mediated impairments in synaptic function through IFN-γ/Arginase1 signaling[J].Brain Behav Immun,2018,71(6):116-132.
[10] Yong YK. Decrease of CD69 levels on TCR Vα7.2+ CD4+innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients[J].Innate Immunity,2017,23(5):459-467.
[11] Lei Y, Hu T, Song X, et al. Production of autoantibodies in chronic hepatitis b virus infection is associated with the augmented function of blood CXCR5+CD4+ T cells[J].PLoS One,2016,11(9):241-243.
[12] Yang J. The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4+CD25+ regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment[J].Cell Mole Immunol,2016,13(5):678-687.
[13] 张丹,李明慧,屈晓晶,等. HBV不同感染状态患者CD4+T细胞功能的差异研究[J].中华实验和临床病毒学杂志,2016,30(2):185-188.
2019, Vol. 36 
